Pfizer PFE
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Pfizer (PFE) Business Model and Operations Summary
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Key Insights
Pfizer (PFE) Core Market Data and Business Metrics
Latest Closing Price
$24.54Market Cap
$139.35 BillionAverage Daily Trade Volume
44,876,698 SharesPrice-Earnings Ratio
17.40Total Outstanding Shares
5.67 Billion SharesCEO
Dr. Albert Bourla D.V.M., Ph.D.Total Employees
81,000Dividend
$0.43 Per Share QuarterlyIPO Date
June 22, 1951SIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
66 Hudson Boulevard East, New York, NY, 10001-2192
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-17.14 Billion |
| Net Cash Flow, Continuing | $-1.74 Billion |
| Exchange Gains/Losses | $-66 Million |
| Net Cash Flow From Operating Activities | $12.74 Billion |
| Net Cash Flow | $-1.81 Billion |
| Net Cash Flow From Operating Activities, Continuing | $12.74 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Discontinued Operations Net Of Tax | $11 Million |
| Income Tax Expense/Benefit | $-28 Million |
| Income/Loss From Continuing Operations Before Tax | $8.02 Billion |
| Operating Expenses | $37.75 Billion |
| Costs And Expenses | $55.60 Billion |
| Basic Earnings Per Share | $1.42 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $116 Million |
| Comprehensive Income/Loss Attributable To Parent | $8.15 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $28 Million |
| Comprehensive Income/Loss | $8.18 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $163.04 Billion |
| Equity Attributable To Parent | $88.20 Billion |
| Equity Attributable To Noncontrolling Interest | $294 Million |
| Equity | $88.50 Billion |
| Current Assets | $50.36 Billion |
| Other Non-current Assets | $89.23 Billion |
Historical Dividends
Current dividend: $0.43 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Dec 12, 2024 | Mar 7, 2025 | Jan 24, 2025 | $0.43 | Quarterly |
| Oct 9, 2024 | Dec 2, 2024 | Nov 8, 2024 | $0.42 | Quarterly |
| Jun 26, 2024 | Sep 3, 2024 | Jul 26, 2024 | $0.42 | Quarterly |
| Apr 24, 2024 | Jun 14, 2024 | May 10, 2024 | $0.42 | Quarterly |
| Dec 14, 2023 | Mar 1, 2024 | Jan 26, 2024 | $0.42 | Quarterly |
| Oct 4, 2023 | Dec 4, 2023 | Nov 10, 2023 | $0.41 | Quarterly |